Allogene Therapeutics Initiates Industry’s First Allogeneic CAR T Phase 2 Trial
Go back to Allogene Therapeutics Initiates Industry’s First Allogeneic CAR T Phase 2 Trial| (NASDAQ: ALLO) | Delayed: 1.65 -0.02 (1.2%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.67 | 52 Week High | $ | |||
| Open | $1.69 | 52 Week Low | $ | |||
| Day High | $1.70 | P/E | N/A | |||
| Day Low | $1.63 | EPS | $ | |||
| Volume | 3,621,657 | |||||
